Literature DB >> 20127591

Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug.

R E Kast1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20127591     DOI： 10.1055/s-0029-1242756

Source DB:  PubMed          Journal:  Cent Eur Neurosurg        ISSN： 1868-4904


× No keyword cloud information.
  7 in total

1.  A Quantitative Chemoproteomic Platform to Monitor Selenocysteine Reactivity within a Complex Proteome.

Authors:  Daniel W Bak; Jinjun Gao; Chu Wang; Eranthie Weerapana
Journal:  Cell Chem Biol       Date:  2018-07-05       Impact factor: 8.116

Review 2.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

3.  A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.

Authors:  Andrea Ilari; Paola Baiocco; Luigi Messori; Annarita Fiorillo; Alberto Boffi; Marina Gramiccia; Trentina Di Muccio; Gianni Colotti
Journal:  Amino Acids       Date:  2011-08-11       Impact factor: 3.520

Review 4.  Organometallic gold(I) and gold(III) complexes for lung cancer treatment.

Authors:  Juzheng Zhang; Yanping Li; Ronghao Fang; Wei Wei; Yong Wang; Jiamin Jin; Feng Yang; Jian Chen
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

Review 5.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04

6.  High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.

Authors:  Xiaobin Luo; Shangyi Xu; Yali Zhong; Tianqi Tu; Youlin Xu; Xianglong Li; Bin Wang; Fubing Yang
Journal:  Oncol Lett       Date:  2019-10-14       Impact factor: 2.967

7.  CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Suhua Chen; Chenlong Yang; Jun Yang
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.